STAGE IVA NASOPHARYNGEAL CARCINOMA
Clinical trials for STAGE IVA NASOPHARYNGEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new STAGE IVA NASOPHARYNGEAL CARCINOMA trials appear
Sign up with your email to follow new studies for STAGE IVA NASOPHARYNGEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood test could guide chemo for throat cancer patients
Disease control OngoingThis study tests whether a blood test for Epstein-Barr virus (EBV) DNA can help doctors choose the best chemotherapy after standard radiation for nasopharyngeal cancer. About 685 patients will first receive standard chemoradiation. Then, based on whether EBV DNA is still detectab…
Matched conditions: STAGE IVA NASOPHARYNGEAL CARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New combo therapy shows promise for advanced nose cancer
Disease control OngoingThis study tests a treatment plan for people with stage IVA nasopharyngeal cancer (a type of nose and throat cancer). Participants receive a combination of the immunotherapy drug pembrolizumab and chemotherapy before and during radiation, followed by maintenance pembrolizumab for…
Matched conditions: STAGE IVA NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC